This webinar will discuss recent advances in immunotherapy clinical trial designs, especially those incorporating novel combinations, that are helping to improve patient experiences and accelerate the development of more cures.
The Sixth CRI-ENCI-AACR International Cancer Immunotherapy Conference: Translating Science Into Survival will take place in autumn 2022 in New York City.
This webinar will explore how the different branches of the immune system works, and how we’re tapping into its immense and diverse capabilities in order to conquer all forms of cancer via a wide variety of immunotherapy approaches.
The Cancer Research Institute (CRI) assembles a team to run the 2022 TCS New York City Marathon.
Be a part of the global generosity movement and celebrate all acts of giving. #GivingTuesday
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Rare and ultra-rare cancers affect around 20,000 people in the United States alone, according to Foundation Medicine, Inc. Immunotherapy research in some of the more common cancers and the identification of biomarkers that can predict patient responses is opening this new approach to cancer treatment up to patients whose cancers currently receive little direct attention.
Cancer is not “one-size-fits-all” and neither are its treatments, especially when it comes to immunotherapy. Learn how CRI is helping more people overcome cancer.